US NIH (National Institutes of Health) funds revascularisation trial:
This article was originally published in Clinica
The US National Institutes of Health is to begin a five-year study, called the Occluded Artery Trial, to evaluate the effectiveness of routinely opening occluded infarct-related arteries during convalescence after heart attack. The trial, which is due to start this quarter, will randomise 3,200 patients at over 300 hospitals worldwide to invasive or non-invasive revascularisation strategies to address long-term safety, efficacy and cost implications of the procedures. Patient cases will be assessed using Westerly, Rhode Island-based Heartlab's DICOMview angiographic review software.